← Open Payments lookup

STEPHANIE MCKAY: Open Payments

NPI 1710603865 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,337 in 61 payments from 17 companies in 2025. Trend: 2023 $2,144 · 2024 $2,653 · 2025 $1,337

Food & beverage: $1,337
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$192
Neurocrine BioSciences, Inc.7$153
Otsuka America Pharmaceutical, Inc.7$142
Axsome Therapeutics, Inc.10$135
Lundbeck LLC4$108
Janssen Pharmaceuticals, Inc4$94
Alkermes, Inc.3$87
E.R. Squibb & Sons, L.L.C.3$86
Vanda Pharmaceuticals Inc.3$70
Tris Pharma Inc3$51

Products named: REXULTI, CAPLYTA, INGREZZA, Auvelity, COBENFY, LYBALVI, INVEGA SUSTENNA, Dyanavel XR.

Industry payments across DE — which companies pay providers there.